CSIR launches India's first ayurvedic anti-diabetic drug named BGR-34

Published: February 3, 2016

The Council for Scientific and Industrial Research (CSIR) has launched the country’s first anti-diabetic ayurvedic drug named BGR-34 for type two Diabetes mellitus. BGR-34 stands for Blood Glucost Regulator and offers effective, safe, patient-friendly solution for managing type two Diabetes. About BGR-34 The drug has been jointly developed by National Botanical Research Institute (NBRI) and ..

Month: Current Affairs - February, 2016

Topics: Ayurveda • BGR 34 • CSIR • Current Affairs 2016 • Diabetes • Diseases

Advertisement